ASLAN Pharmaceuticals (Nasdaq: ASLN), is one of Asia’s leading biotech companies focusing on clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is led by a team of veterans from the industry, and has partnerships with global pharma and biotech companies. ASLAN is headquartered in Singapore and has subsidiaries in Taiwan, Australia & China and listing in US Nasdaq market from 2018.
ASLAN Pharmaceuticals (Nasdaq: ASLN), is one of Asia’s leading biotech companies focusing on clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is led by a team of veterans from the industry, and has partnerships with global pharma and biotech companies. ASLAN is headquartered in Singapore and has subsidiaries in Taiwan, Australia & China and listing in US Nasdaq market from 2018.
ASLAN Pharmaceuticals (Nasdaq: ASLN), is one of Asia’s leading biotech companies focusing on clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is led by a team of veterans from the industry, and has partnerships with global pharma and biotech companies. ASLAN is headquartered in Singapore and has subsidiaries in Taiwan, Australia & China and listing in US Nasdaq market from 2018.